Core Insights - GE HealthCare (GEHC) reported fourth-quarter 2024 adjusted earnings per share (EPS) of 1.26 by 15.1%, and showing a year-over-year improvement of 22.9% [1] - The company's shares gained 0.7% in pre-market trading following the earnings report, with a 3% increase over the past six months compared to the industry's 12.8% growth [2] - Total revenues for the fourth quarter were 19.67 billion, reflecting a 1% year-over-year increase [4] Segment Performance - Imaging segment revenues were 302 million, up 19% [5] - Advanced Visualization Solutions generated revenues of 374 million, up 15% [7] - Patient Care Solutions revenues were 106 million [7] - Pharmaceutical Diagnostics revenues totaled 212 million, up 47% [7] Margins and Cash Flow - The net income margin improved to 13.5%, up 580 basis points from the prior year, attributed to productivity and pricing benefits [8] - Cumulative cash flow from operating activities at the end of the fourth quarter was 2.1 billion a year ago [8] Financial Position - GEHC ended the fourth quarter with cash, cash equivalents, and investments of 3.57 billion in the previous quarter [9] - Total assets decreased to 33.86 billion sequentially [9] 2025 Guidance - For 2025, GE HealthCare expects adjusted EPS in the range of 4.75, indicating a year-over-year growth of 3-6% [10] - Revenues are anticipated to grow 2-3% organically, reflecting continued demand for its products and services [10]
GE HealthCare Q4 Earnings Beat Estimates, Sales Miss, Net Margin Rises